Conference Description:

Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.

Expand your knowledge and discuss future priorities in:
- Biomarker Analysis - Multiplex Technology Application & Translational Research
- Biomarker Development for Drug Discovery & Translational Research
- Emerging Approaches for Biomarker Analysis
& much more!

Meet key decision makers representing large pharma & biotech companies:

- Stephanie Traub (Associate Director, Bioanalytical Scientific Manager, Translational Biomarkers & Bioanalysis, UCB)
- Rob Slack (Vice President & Head of Pharmacology, Galecto)
- Guillaume Desachy (Statistical Science Director, Late-Stage Development, Respiratory & Immunology (R&J), Biopharmaceuticals R&D, Astra Zeneca)
- Twan Lammers (Profesor, Head of Department Nanomedicine & Theranostics, Aachen University)
& many more!

View the agenda here to receive the full event details - https://www.oxfordglobal.co.uk/biomarker -analysis/agenda/download-agenda/?utm_so urce=worldconferencecalendar&utm_medium= eventlisting&utm_campaign=biomarkers&utm _content=biomeu2023